The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Bayer
AstraZeneca
Arvinas Inc.
Seagen Inc.
Elicio Therapeutics
Merck Sharp & Dohme LLC
Elevation Oncology
DxTerity Diagnostics
MacroGenics
INSYS Therapeutics Inc